Lori Vaz

Lori Vaz is a biotech transformational leader with over 15 years of experience in patient support and access for specialty care and rare diseases. They currently lead Program Optimization for Dupixent MyWay, supporting more than 300,000 patients across various indications. In previous roles at Sanofi Genzyme, Lori directed patient support teams and served as a trusted advocate for rare disease patients, ensuring seamless access to care. Lori's educational background includes a degree in Communications/Journalism from Gordon College. Known for bridging strategy with empathy, they focus on designing data-informed service models that enhance patient experiences and outcomes.